Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo.

by Arno W R van Kuijk, Jeroen DeGroot, Rishma C Koeman, Nico Sakkee, Dominique L Baeten, Danielle M Gerlag, Paul P Tak
Published 2010-01-01

Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice

by Leonieke J. J. van Mens, Marleen G. H. van de Sande, Inka A. Fluri, Sadaf Atiqi, Arno W. R. van Kuijk, Dominique L. P. Baeten
Published 2017-10-01

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension...

by Henriëtte M. Y. de Jong, Leonieke J. J. van Mens, Michael T. Nurmohamed, Marc R. Kok, Arno W. R. van Kuijk, Dominique L. P. Baeten, Marleen G. H. van de Sande
Published 2019-09-01